To further validate the role of miR-31 in modulating the stemness properties of HNSCC cells, the Nanog/OCT4/Sox2 protein expression was determined in OECM1 and FaDu cells treated with miR-31 mimic or miR-31 inhibitor. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.